Cetuximab improves locoregional control and survival of locoregionally advanced head and neck cancer: Independent review of mature data with a median follow-up of 45 months

J. A. Bonner, P. M. Harari, J. Giralt, N. Azarnia, R. B. Cohen, C. Jones, R. Sur, D. Raben, J. Baselga, S. Spencer, N. Amellal, E. Rowinsky, K. K. Ang

Research output: Contribution to journalArticleResearchpeer-review

Cite this